cik stringclasses 1
value | date stringlengths 8 8 | form stringclasses 4
values | sentenceCount int64 0 2.33k | sentence stringlengths 2 5.25k | filename stringlengths 40 40 |
|---|---|---|---|---|---|
0000320193 | 20181105 | 10-K | 871 | Advertising Costs
Advertising costs are expensed as incurred and included in selling, general and administrative expenses. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 872 | Apple Inc. | 2018 Form 10-K | 44
Share-Based Compensation
The Company generally measures share-based compensation based on the closing price of the Company’s common stock on the date of grant, and recognizes expense on a straight-line basis for its estimate of equity awards that will ultimately vest. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 873 | Further information regarding share-based compensation can be found in Note 8, “Benefit Plans.”
During the first quarter of 2018, the Company adopted the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Update (“ASU”) No. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 874 | 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), which modified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 875 | Historically, excess tax benefits or deficiencies from the Company’s equity awards were recorded as additional paid-in capital in its Consolidated Balance Sheets and were classified as a financing activity in its Consolidated Statements of Cash Flows. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 876 | Beginning in 2018, the Company records any excess tax benefits or deficiencies from its equity awards as part of the provision for income taxes in its Consolidated Statements of Operations in the reporting periods in which equity vesting occurs. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 877 | The Company elected to apply the cash flow classification requirements related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to cash generated by operating activities in the Consolidated Statements of Cash Flows of $627 million and $407 million for 2017 and 2016, respect... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 878 | Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for 2018, 2017 and 2016 (net income in millions and shares in thousands):
Cash Equivalents and Marketable Securities
All highly liquid investments with maturities of three months or less at the date of purchase are clas... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 879 | The Company’s marketable debt and equity securities have been classified and accounted for as available-for-sale. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 880 | The Company classifies its marketable debt securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 881 | Marketable equity securities, including mutual funds, are classified as short-term based on the nature of the securities and their availability for use in current operations. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 882 | The cost of securities sold is determined using the specific identification method. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 883 | Inventories
Inventories are computed using the first-in, first-out method. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 884 | Property, Plant and Equipment
Depreciation on property, plant and equipment is recognized on a straight-line basis over the estimated useful lives of the assets, which for buildings is the lesser of 30 years or the remaining life of the underlying building; between one and five years for machinery and equipment, includ... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 885 | Capitalized costs related to internal-use software are amortized on a straight-line basis over the estimated useful lives of the assets, which range from three to five years. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 886 | Depreciation and amortization expense on property and equipment was $9.3 billion, $8.2 billion and $8.3 billion during 2018, 2017 and 2016, respectively. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 887 | During 2018, non-cash investing activities involving property, plant and equipment resulted in a net increase to accounts payable and other current liabilities of $3.4 billion. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 888 | Apple Inc. | 2018 Form 10-K | 45
Fair Value Measurements
The Company’s valuation techniques used to measure the fair value of money market funds and certain marketable equity securities are derived from quoted prices in active markets for identical assets or liabilities. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 889 | The valuation techniques used to measure the fair value of the Company’s debt instruments and all other financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable ma... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 890 | Note 2 - Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash and available-for-sale securities by significant investment category as of September 29, 2018 and September 30, 2017 (in millions):
Apple Inc. | 2018 Form 10-K | 46
(1)
Level 1 fair value estimat... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 891 | (2)
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for subs... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 892 | (3)
As of September 29, 2018, total cash, cash equivalents and marketable securities included $20.3 billion that was restricted from general use, related to the State Aid Decision (refer to Note 4, “Income Taxes”) and other agreements. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 893 | The Company may sell certain of its marketable securities prior to their stated maturities for reasons including, but not limited to, managing liquidity, credit risk, duration and asset allocation. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 894 | The maturities of the Company’s long-term marketable securities generally range from one to five years. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 895 | The following tables show information about the Company’s marketable securities that had been in a continuous unrealized loss position for less than 12 months and for 12 months or greater as of September 29, 2018 and September 30, 2017 (in millions):
Apple Inc. | 2018 Form 10-K | 47
The Company typically invests in hig... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 896 | The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 897 | Fair values were determined for each individual security in the investment portfolio. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 898 | When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whe... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 899 | As of September 29, 2018, the Company does not consider any of its investments to be other-than-temporarily impaired. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 900 | Derivative Financial Instruments
The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, net investments in certain foreign subsidiaries, and certain existing assets and liabilities. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 901 | However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations or the prohibitive economic cost of hedging particular exposures. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 902 | There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 903 | To protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar may hedge a portion of forecaste... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 904 | The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 905 | The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 906 | To protect the net investment in a foreign operation from fluctuations in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset a portion of the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 907 | In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as hedges of its net investments in certain foreign subsidiaries. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 908 | In both of these cases, the Company designates these instruments as net investment hedges. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 909 | To protect the Company’s foreign currency-denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, cross-currency swaps or other instruments. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 910 | These instruments may offset a portion of the foreign currency remeasurement gains or losses, or changes in fair value. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 911 | The Company may designate these instruments as either cash flow or fair value hedges. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 912 | As of September 29, 2018, the Company’s hedged term debt- and marketable securities-related foreign currency transactions are expected to be recognized within 24 years. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 913 | The Company may also enter into non-designated foreign currency contracts to offset a portion of the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 914 | To protect the Company’s foreign currency-denominated term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other instruments. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 915 | These instruments may offset a portion of the changes in interest income or expense, or changes in fair value. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 916 | The Company designates these instruments as either cash flow or fair value hedges. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 917 | As of September 29, 2018, the Company’s hedged interest rate transactions are expected to be recognized within 9 years. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 918 | Cash Flow Hedges
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income/(loss) (“AOCI”) until the hedged item is recognized in earnings. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 919 | Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in th... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 920 | Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 921 | For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 922 | The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 923 | Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 924 | Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into other income/(expense), net in the period of de-designation. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 925 | Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 926 | Apple Inc. | 2018 Form 10-K | 48
Net Investment Hedges
The effective portions of net investment hedges are recorded in other comprehensive income/(loss) (“OCI”) as a part of the cumulative translation adjustment. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 927 | The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 928 | For forward exchange contracts designated as net investment hedges, the Company excludes changes in fair value relating to changes in the forward carry component from its definition of effectiveness. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 929 | Accordingly, any gains or losses related to this forward carry component are recognized in earnings in the current period. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 930 | Fair Value Hedges
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item in the same line in the Consolidated Statements of Operations. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 931 | Non-Designated Derivatives
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 932 | As a result, during 2018, the Company recognized a gain of $20 million in net sales, a gain of $85 million in cost of sales and a loss of $198 million in other income/(expense), net. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 933 | During 2017, the Company recognized a gain of $20 million in net sales, a loss of $40 million in cost of sales and a gain of $606 million in other income/(expense), net. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 934 | The Company records all derivatives in the Consolidated Balance Sheets at fair value. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 935 | The Company’s accounting treatment for these derivative instruments is based on its hedge designation. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 936 | The following tables show the Company’s derivative instruments at gross fair value as of September 29, 2018 and September 30, 2017 (in millions):
(1)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets and other non-current assets in the Consolidated B... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 937 | (2)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as other current liabilities and other non-current liabilities in the Consolidated Balance Sheets. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 938 | The Company classifies cash flows related to derivative financial instruments as operating activities in its Consolidated Statements of Cash Flows. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 939 | Apple Inc. | 2018 Form 10-K | 49
The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Consolidated Statements of Operations for 2018, 2017 and 2016 (in millions):
The following table... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 940 | The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 941 | The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 942 | Although the table above reflects the notional and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 943 | The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 944 | Apple Inc. | 2018 Form 10-K | 50
The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 945 | To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 946 | The Company presents its derivative assets and derivative liabilities at their gross fair values in its Consolidated Balance Sheets. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 947 | As of September 29, 2018, the net cash collateral posted by the Company related to derivative instruments under its collateral security arrangements was $1.0 billion, which was recorded as other current assets in the Condensed Consolidated Balance Sheet. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 948 | As of September 30, 2017, the net cash collateral received by the Company related to derivative instruments under its collateral security arrangements was $35 million, which was recorded as other current liabilities in the Consolidated Balance Sheet. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 949 | Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 950 | As of September 29, 2018 and September 30, 2017, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $2.1 billion and $1.4 billion, respectively, resulting i... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 951 | Accounts Receivable
Trade Receivables
The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, resellers, small and mid-sized businesses and education, enterprise and government customers. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 952 | The Company generally does not require collateral from its customers; however, the Company will require collateral or third-party credit support in certain instances to limit credit risk. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 953 | In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 954 | These credit-financing arrangements are directly between the third-party financing company and the end customer. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 955 | As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 956 | As of September 29, 2018, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 10%. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 957 | As of September 30, 2017, the Company had two customers that individually represented 10% or more of total trade receivables, each of which accounted for 10%. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 958 | The Company’s cellular network carriers accounted for 59% of total trade receivables as of both September 29, 2018 and September 30, 2017. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 959 | Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture sub-assemblies or assemble final products for the Company. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 960 | The Company purchases these components directly from suppliers. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 961 | As of September 29, 2018, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 62% and 12%. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 962 | As of September 30, 2017, the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 42%, 19% and 10%. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 963 | Note 3 - Consolidated Financial Statement Details
The following tables show the Company’s consolidated financial statement details as of September 29, 2018 and September 30, 2017 (in millions):
Property, Plant and Equipment, Net
Apple Inc. | 2018 Form 10-K | 51
Other Non-Current Liabilities
Other Income/(Expense), Net
... | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 964 | The Act lowered the Company’s U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018, while also imposing a deemed repatriation tax on previously deferred foreign income. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 965 | The Act also created a new minimum tax on certain future foreign earnings. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 966 | The impact of the Act increased the Company’s provision for income taxes by $1.5 billion during 2018. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 967 | This increase was composed of $2.0 billion related to the remeasurement of net deferred tax assets and liabilities and $1.2 billion associated with the deemed repatriation tax, partially offset by a $1.7 billion impact the deemed repatriation tax had on the Company’s unrecognized tax benefits. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 968 | Deferred Tax Balances
As a result of the Act, the Company remeasured certain deferred tax assets and liabilities based on the revised rates at which they are expected to reverse, including items for which the related income tax effects were originally recognized in OCI. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 969 | In addition, the Company elected to record certain deferred tax assets and liabilities related to the new minimum tax on certain future foreign earnings. | 0000320193-18-000145/full-submission.txt |
0000320193 | 20181105 | 10-K | 970 | Of the $2.0 billion recognized related to the remeasurement of net deferred tax assets and liabilities, $1.2 billion is a provisional estimate that incorporates assumptions based upon the most recent interpretations of the Act and may change as the Company continues to analyze the impact of additional implementation gu... | 0000320193-18-000145/full-submission.txt |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.